|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients显示文摘 | Schuller J Cassidy J Dumont E | 2000 | Cancer Chemother Pharmacol2000，45，： | 2 |
| 2 | Induction of the PAOhl/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells 显示文摘 | DEVEREUX W WANG Y STEWART TM | 2003 | Cancer Chemother Pharmacol2003，52，5： | 1 |
| 3 | The effect of gefitinib ( Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines 显示文摘 | Xu JM Azzariti A Colucci G | 2003 | Cancer Chemother Pharmacol2003，52，6： | 1 |
| 4 | Tissue distribution of doxorubicin associated with polyisohexyanoacrylate nanoparticles显示文摘 | Verdun C Brasseur F Vranckx H | 1990 | Cancer Chemother Pharmacol1990，26，1： | 1 |
| 5 | Pharmacokinetics of imatinib mesylate in end stage renal disease:A case study 显示文摘 | pappaps P Karavasilis V Briasoulis E | 2005 | Cancer Chemother Pharmacol2005，56，： | 1 |
| 6 | Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase Ⅱ California Cancer Consortium Trial显示文摘 | Lara PN Jr Gandara DR Longmate J | 2001 | Cancer Chemother Pharmacol2001，48，1： | 1 |
| 7 | Repression of telomerase reverse transcriptase mRNA and hTERT promoter by inhibitory effects of oncogene C-myc in gambogic acid treated-human gastric carcinoma cells显示文摘 | Guo QL You QD | 2006 | Cancer Chemother Pharmacol2006，58，6： | 1 |
| 8 | Cytocidal effect and DNA damag of nedaplatin in vitro by simulating pharmacokinetic parameters显示文摘 | Miyagi Y Yamamoto J | 2001 | Cancer Chemother Pharmacol2001，47，4： | 1 |
| 9 | Characterization of tetrandrine,a potent inhibitor of P - glycoprotein - mediated multidrug resistance显示文摘 | Liang Y Deng L | 2004 | Cancer Chemother Pharmacol2004，53，4： | 1 |
| 10 | Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer显示文摘 | Zhang Z Omoto Y | 2003 | Cancer Chemother Pharmacol2003，52，1： | 1 |
| 11 | A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer显示文摘 | MORIZANE C OKUSAKA T FURUSE J | 2009 | Cancer Chemother Pharmacol2009，63，2： | 1 |
| 12 | Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer显示文摘 | Di Re F Bohm S Oriana S | 1990 | Cancer Chemother Pharmacol1990，25，5： | 1 |
| 13 | Phase Ⅱ study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours 显示文摘 | Caraglia M Addeo R Costanzo R | 2006 | Cancer Chemother Phannacol2006，57，1： | 1 |
| 14 | Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress显示文摘 | YAMADA M TOMIDA A YUN J | 1999 | Cancer Chemother Pharmacol1999，44，1： | 1 |
| 15 | Inhibition of fludarabine metabolism by arabinosylcytosine during therapy显示文摘 | Kemena A Gandhi V Shewach DS | 1992 | Cancer Chemother Pharmacol1992，31，3： | 1 |
| 16 | A phase l1 study of pacli- taxe combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer显示文摘 | Im CK Jeung HC Rha SY | 2008 | Cancer Chemother Pharmacol2008，61，2： | 1 |
| 17 | Nitric oxide: role in tumour biology and iNOS/ NO-based anticancer therapies显示文摘 | SINGH S GUPTA A K | 2011 | Cancer Chemother Pharmacol2011，67，6： | 1 |
| 18 | High-dose toremifene as a cisplatin modulator in metastatic non-small-cell lung cancer:targed plasma levels are achievable clinically显示文摘 | Lara PN Jr Gandara DR Wurz GT | 1998 | Cancer Chemother Pharmacol1998，42，6： | 1 |
| 19 | The effect of vincristinepolyanion complexes in STEALTH liposomes on pharmacokinetics, toxicity, and antitumor activity 显示文摘 | Zhu G Oto E Vaage J | 1996 | Cancer Chemother Pharmacol1996，39，12： | 1 |
| 20 | CAP(cyclophosphamide,adriamycin,platinum) vs CMFVP(cyclophosphamide,methorrexate,5-florouracil,Vincristin,prednisone) combination chemotherapy in untreated metastatic breast cancer显示文摘 | Kolaric K Roth A Vukas D | 1984 | Cancer Chemother Pharmacol1984，13，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员